Kodiak Sciences (KOD) Research Hub

Kodiak Sciences (KOD) trades on NASDAQ, US in the Healthcare (Biotechnology) sector. As of 2026-10-26, shares last closed at 89.6 USD (+2.25%), in a range — insufficient history for 200-DMA. Valuation: trailing P/E -10.05, market cap 2.22B. This hub links to the full technical, earnings and options research available for KOD.

Last updated 2026-10-26 · Source: end-of-day prices (adjusted); indicators computed by SniperIQ

SectorHealthcare (Biotechnology)
ExchangeNASDAQ, US
Last close89.6 USD (+2.25%)
52-week range29.81 USD – 104 USD
Trend regimeRange
14-day RSI47.6 (Neutral)
Trailing P/E-10.05
Market cap2.22B
Dividend yield0.00%
Next earnings2026-08-12

Available research for KOD

Earnings

KOD earnings date and last-quarter result: next report 2026-08-12, last quarter miss, P/E -10.05. Updated 2026-07-23.

Options: Covered Call

Covered Call on KOD: how it works, illustrative setup around the real 89.6 USD price, max profit/loss, breakeven and when to use it. Educational.

Options: Iron Condor

Iron Condor on KOD: how it works, illustrative setup around the real 89.6 USD price, max profit/loss, breakeven and when to use it. Educational.

Options: Protective Put

Protective Put on KOD: how it works, illustrative setup around the real 89.6 USD price, max profit/loss, breakeven and when to use it. Educational.

Technical

KOD technical analysis: range, last 89.6 USD, RSI 47.6, 52w range 29.81 USD–104 USD, real support/resistance. Updated 2026-10-26.

More on SniperIQ

Frequently asked questions

What sector is KOD in?

Kodiak Sciences (KOD) is classified under Healthcare (Biotechnology), listed on NASDAQ, US.

Is KOD in an uptrend or downtrend?

As of 2026-10-26, KOD is in a range — insufficient history for 200-DMA. See the full technical research page for support and resistance levels.

What is KOD's trailing P/E ratio?

KOD's trailing P/E is -10.05, with a market cap of 2.22B. See the earnings research page for full valuation detail.

When does KOD next report earnings?

KOD is next scheduled to report earnings on 2026-08-12.